Axerion Therapeutics Sees New Investment


	Subscribe \| Contact Us \|

Thursday, April 08, 2010 5:32:00 AM PDT | VentureDeal Staff

New Haven, Connecticut -- Pharmaceutical startup company Axerion Therapeutics (no website) has raised $750,000 in seed financing.

Axerion is a very early stage company focused on neurological diseases including axon regeneration therapy for CNS injuries.

Connecticut Innovations made the investment. The company did not disclose how the funding proceeds would be used.

Email Page | Print Page

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.